Northern Trust’s Kalaris Therapeutics KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $67.1K | Buy |
|
|||||
|
2024
Q3 | $128K | Sell |
|
|||||
|
2024
Q2 | $316K | Sell |
|
|||||
|
2024
Q1 | $339K | Buy |
|
|||||
|
2023
Q4 | $292K | Sell |
|
|||||
|
2023
Q3 | $1.02M | Sell |
|
|||||
|
2023
Q2 | $1.75M | Buy |
|
|||||
|
2023
Q1 | $1.75M | Sell |
|
|||||
|
2022
Q4 | $2.36M | Buy |
|
|||||
|
2022
Q3 | $3.59M | Buy |
|
|||||
|
2022
Q2 | $1.09M | Sell |
|
|||||
|
2022
Q1 | $1.92M | Sell |
|
|||||
|
2021
Q4 | $3.86M | Buy |
|
|||||
|
2021
Q3 | $7.4M | Buy |
|
|||||
|
2021
Q2 | $5.72M | Sell |
|
|||||
|
2021
Q1 | $6.82M | Buy |
|
|||||
|
2020
Q4 | $8.19M | Sell |
|
|||||
|
2020
Q3 | $5.88M | Buy |
|